Pre-Print Publication

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

View

Pre-Print Publication

Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors

View

Peer-Reviewed Publication

Absolute concentration estimation of COVID- 19 convalescent and post-vaccination IgG antibodies

View

Peer-Reviewed Publication

A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability

View

Peer-Reviewed Publication

Nature Medicine: A candidate antibody drug for prevention of malaria

View

Peer-Reviewed Publication

Nature Scientific Reports: High‑throughput analysis system of interaction kinetics for data‑driven antibody design

View

Peer-Reviewed Publication

Direct selection of functional fluorescent-protein antibody fusions by yeast display

View

Peer-Reviewed Publication

TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms

View

Peer-Reviewed Publication

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

View

Peer-Reviewed Publication

Antibodies: Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBDoftheSARS-CoV-2 Spike Protein

View

Peer-Reviewed Publication

Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy

View

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

View

Peer-Reviewed Publication

Cell Reports: Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

View

Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

View